[시장보고서]대장 스크리닝 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문별 예측(2026-2033년)

대장 스크리닝 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문별 예측(2026-2033년)

Colon Screening Market Size, Share & Trends Analysis Report By Type (Test, Product), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2026 - 2033

상품코드 : 1941530

리서치사 : Grand View Research

발행일 : 2026년 01월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,957,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,462,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,473,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

대장 스크리닝 시장 요약

세계의 대장 스크리닝 시장 규모는 2025년에 404억 1,000만 달러로 추정되며, 2033년까지 576억 5,000만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 4.60%로 성장할 것으로 예상됩니다. 대장암 발병률 증가, 암 검진을 촉진하기 위한 정부의 노력 강화, 시장의 지속적인 기술 발전이 이 시장의 성장을 이끄는 주요 요인으로 꼽힙니다.

예를 들어, 2023년 12월, 메드트로닉은 내시경 검사 중 건강 문제를 자동으로 감지하는 플러그인 소프트웨어 개발사인 코스모제약과 인공지능(AI) 분야로 협업을 확대했습니다.

대장 질환의 증가 추세는 대장 검진 산업의 성장을 이끄는 주요 요인입니다. 심각한 소화기 질환인 대장암은 세계에서 세 번째로 많이 진단되는 암이며, 암 관련 사망 원인 중 두 번째로 많은 암입니다. 이러한 증가 추세는 조기 발견과 효과적인 검진 방법의 필요성을 강하게 시사하고 있습니다. 국제암연구소(IARC)에 따르면, 전 세계적으로 연간 약 190만 건의 신규 대장암이 보고되고 있으며, 가장 빈번하게 발생하는 악성 종양 중 하나입니다. 세계보건기구(WHO)는 유럽, 호주, 뉴질랜드 등의 지역에서 발병률이 가장 높다는 점을 강조하며, 그 주요 요인으로 생활습관, 식습관, 고령화 등을 꼽고 있습니다.

영문목차

Colon Screening Market Summary

The global colon screening market size was estimated at USD 40.41 billion in 2025 and projected to reach USD 57.65 billion by 2033, growing at a CAGR of 4.60% from 2026 to 2033. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the growth of this market.

For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

The increasing prevalence of colorectal diseases is a major driver of growth in the colon screening industry. Colorectal cancer, a severe gastrointestinal condition, ranks as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Its growing incidence highlights the critical need for early detection and effective screening methods. According to the International Agency for Research on Cancer (IARC), approximately 1.9 million new cases of colorectal cancer are reported annually across the globe, making it one of the most prevalent malignancies. The World Health Organization further emphasizes that regions such as Europe, Australia, and New Zealand exhibit the highest incidence rates, primarily due to lifestyle factors, diet, and aging populations.

Global Colon Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides the analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global colon screening market report based on type, end use, and region:

Type Outlook (Revenue, USD Million, 2021 - 2033)
Test
- Colonoscopy
- Capsule Endoscopy
- Imaging Tests
- Virtual Colonoscopy
- Magnetic resonance colonography (MRC)
- Others
- End Use, By Test
- Hospitals
- Outpatient Facilities
Product
- Colonoscopes
- Sigmoidoscopes
- CT Scanners
- Magnetic Resonance Imaging (MRI)
- End Use, By Product
- Hospitals
- Outpatient Facilities
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Product outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Colon Screening Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Colon Screening: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
3.4. Case Study Analysis
3.5. Recent Launches of Colon Screening Programs
3.6. Technological Innovation in the Products used in Colon Screenings

Chapter 4. Colon Screening Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

4.1. Definition and Scope
4.2. Type Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Colon Screening Market, by Type, 2021 to 2033
4.5. Test
- 4.5.1. Test Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Colonoscopy
  - 4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Capsule Endoscopy
  - 4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Imaging Tests
  - 4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.4.2. Virtual Colonoscopy
    - 4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.4.3. Magnetic resonance colonography (MRC)
    - 4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.5. Others
  - 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.6. End Use, By Test
  - 4.5.6.1. Hospitals
    - 4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.6.2. Outpatient Facilities
    - 4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Product
- 4.6.1. Product Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Colonoscopes
  - 4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Sigmoidoscopes
  - 4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.4. CT Scanners
  - 4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.5. Magnetic Resonance Imaging (MRI)
  - 4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.6. End Use, By Product
  - 4.6.6.1. Hospitals
    - 4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.6.6.2. Outpatient Facilities
    - 4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Colon Screening Market Segment Analysis, By Region, 2021- 2033 (USD Million)

5.1. Regional Market Share Analysis, 2025 & 2033
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Colon Screening Market Share by Region, 2025 & 2033:
5.5. North America
- 5.5.1. North America colon screening market, 2021 - 2033 (USD Million)
- 5.5.2. U.S.
  - 5.5.2.1. U.S. colon screening market, 2021 - 2033 (USD Million)
- 5.5.3. Canada
  - 5.5.3.1. Canada colon screening market, 2021 - 2033 (USD Million)
- 5.5.4. Mexico
  - 5.5.4.1. Mexico colon screening market, 2021 - 2033 (USD Million)
5.6. Europe
- 5.6.1. Europe colon screening market, 2021 - 2033 (USD Million)
- 5.6.2. UK
  - 5.6.2.1. UK colon screening market, 2021 - 2033 (USD Million)
- 5.6.3. Germany
  - 5.6.3.1. Germany colon screening market, 2021 - 2033 (USD Million)
- 5.6.4. France
  - 5.6.4.1. France colon screening market, 2021 - 2033 (USD Million)
- 5.6.5. Italy
  - 5.6.5.1. Italy colon screening market, 2021 - 2033 (USD Million)
- 5.6.6. Spain
  - 5.6.6.1. Spain colon screening market, 2021 - 2033 (USD Million)
- 5.6.7. Norway
  - 5.6.7.1. Norway colon screening market, 2021 - 2033 (USD Million)
- 5.6.8. Sweden
  - 5.6.8.1. Sweden colon screening market, 2021 - 2033 (USD Million)
- 5.6.9. Denmark
  - 5.6.9.1. Denmark colon screening market, 2021 - 2033 (USD Million)
5.7. Asia Pacific
- 5.7.1. Japan
  - 5.7.1.1. Japan colon screening market, 2021 - 2033 (USD Million)
- 5.7.2. China
  - 5.7.2.1. China colon screening market, 2021 - 2033 (USD Million)
- 5.7.3. India
  - 5.7.3.1. India colon screening market, 2021 - 2033 (USD Million)
- 5.7.4. Australia
  - 5.7.4.1. Australia colon screening market, 2021 - 2033 (USD Million)
- 5.7.5. South Korea
  - 5.7.5.1. South Korea colon screening market, 2021 - 2033 (USD Million)
- 5.7.6. Thailand
  - 5.7.6.1. Thailand colon screening market, 2021 - 2033 (USD Million)
5.8. Latin America
- 5.8.1. Brazil
  - 5.8.1.1. Brazil colon screening market, 2021 - 2033 (USD Million)
- 5.8.2. Argentina
  - 5.8.2.1. Argentina colon screening market, 2021 - 2033 (USD Million)
5.9. MEA
- 5.9.1. South Africa
  - 5.9.1.1. South Africa colon screening market, 2021 - 2033 (USD Million)
- 5.9.2. Saudi Arabia
  - 5.9.2.1. Saudi Arabia colon screening market, 2021 - 2033 (USD Million)
- 5.9.3. UAE
  - 5.9.3.1. UAE colon screening market, 2021 - 2033 (USD Million)
- 5.9.4. Kuwait
  - 5.9.4.1. Kuwait colon screening market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
- 6.3.1. Olympus
  - 6.3.1.1. Company overview
  - 6.3.1.2. Financial performance
  - 6.3.1.3. Platform benchmarking
  - 6.3.1.4. Strategic initiatives
- 6.3.2. PENTAX Medical (Hoya Corporation)
  - 6.3.2.1. Company overview
  - 6.3.2.2. Financial performance
  - 6.3.2.3. Platform benchmarking
  - 6.3.2.4. Strategic initiatives
- 6.3.3. FUJIFILM Holdings Corporation
  - 6.3.3.1. Company overview
  - 6.3.3.2. Financial performance
  - 6.3.3.3. Platform benchmarking
  - 6.3.3.4. Strategic initiatives
- 6.3.4. Medtronic
  - 6.3.4.1. Company overview
  - 6.3.4.2. Financial performance
  - 6.3.4.3. Platform benchmarking
  - 6.3.4.4. Strategic initiatives
- 6.3.5. Ambu A/S
  - 6.3.5.1. Company overview
  - 6.3.5.2. Financial performance
  - 6.3.5.3. Platform benchmarking
  - 6.3.5.4. Strategic initiatives
- 6.3.6. Baxter (Hillrom & Welch Allyn)
  - 6.3.6.1. Company overview
  - 6.3.6.2. Financial performance
  - 6.3.6.3. Platform benchmarking
  - 6.3.6.4. Strategic initiatives
- 6.3.7. EndoFresh (Daichuan medical)
  - 6.3.7.1. Company overview
  - 6.3.7.2. Financial performance
  - 6.3.7.3. Platform benchmarking
  - 6.3.7.4. Strategic initiatives
- 6.3.8. Bracco
  - 6.3.8.1. Company overview
  - 6.3.8.2. Financial performance
  - 6.3.8.3. Platform benchmarking
  - 6.3.8.4. Strategic initiatives
- 6.3.9. Varay Laborix
  - 6.3.9.1. Company overview
  - 6.3.9.2. Financial performance
  - 6.3.9.3. Platform benchmarking
  - 6.3.9.4. Strategic initiatives

한글목차

대장 스크리닝 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 대장 스크리닝 시장 변수, 동향 및 범위

제4장 대장 스크리닝 시장 세분화, 유형별, 2021-2033년

제5장 대장 스크리닝 시장 세분화, 지역별, 2021-2033년

제6장 경쟁 구도